CA2346006A1 - Desaturase d'acide gras delta 6 - Google Patents

Desaturase d'acide gras delta 6 Download PDF

Info

Publication number
CA2346006A1
CA2346006A1 CA002346006A CA2346006A CA2346006A1 CA 2346006 A1 CA2346006 A1 CA 2346006A1 CA 002346006 A CA002346006 A CA 002346006A CA 2346006 A CA2346006 A CA 2346006A CA 2346006 A1 CA2346006 A1 CA 2346006A1
Authority
CA
Canada
Prior art keywords
cyb5rp
protein
cybsrp
seq
delta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002346006A
Other languages
English (en)
Inventor
Konstantin Petrukhin
C. Thomas Caskey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2346006A1 publication Critical patent/CA2346006A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0083—Miscellaneous (1.14.99)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Vascular Medicine (AREA)
  • Transplantation (AREA)
  • Endocrinology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)

Abstract

L'invention porte sur de nouvelles séquences d'ADN humain qui codent le gène CYB5RP et sur une désaturase d'acide gras delta 6. L'invention porte également sur l'ADN génomique CYB5RP, ainsi que sur l'ADNc qui code la protéine CYB5RP. L'invention porte, de plus, sur une protéine CYB5RP codée par les nouvelles séquences d'ADN, sur des procédés d'expression de la protéine CYB5RP dans des systèmes de recombinaison, ainsi que sur des procédés CYB5RP qui identifient les activateurs et les inhibiteurs de la protéine CYB5RP.
CA002346006A 1998-10-09 1999-10-05 Desaturase d'acide gras delta 6 Abandoned CA2346006A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10376098P 1998-10-09 1998-10-09
US60/103,760 1998-10-09
PCT/US1999/023253 WO2000021557A1 (fr) 1998-10-09 1999-10-05 Desaturase d'acide gras delta 6

Publications (1)

Publication Number Publication Date
CA2346006A1 true CA2346006A1 (fr) 2000-04-20

Family

ID=22296902

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002346006A Abandoned CA2346006A1 (fr) 1998-10-09 1999-10-05 Desaturase d'acide gras delta 6

Country Status (4)

Country Link
EP (1) EP1121150A4 (fr)
JP (1) JP2002527051A (fr)
CA (1) CA2346006A1 (fr)
WO (1) WO2000021557A1 (fr)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1035207A1 (fr) * 1999-03-09 2000-09-13 MultiGene Biotech GmbH Molécules d'ADNc des membres de la famille de gènes codant des désaturases d'acides gras humaines, et leur utilisation dans le diagnostic et la thérapie
DE10030976A1 (de) 2000-06-30 2002-01-10 Basf Ag DELTA6-Desaturasegene exprimierende Pflanzen und PUFAS enthaltende Öle aus diesen Pflanzen und ein Verfahren zur Herstellung ungesättigter Fettsäuren
PT1322752E (pt) 2000-09-28 2010-05-06 Bioriginal Food & Science Corp Fad4, fad5, fad5-2 e fad6, novos membros da família de dessaturases de ácidos gordos e susas utilizações
GB2385852A (en) 2002-02-27 2003-09-03 Rothamsted Ex Station Delta 6-desaturases from Primulaceae
DE10219203A1 (de) 2002-04-29 2003-11-13 Basf Plant Science Gmbh Verfahren zur Herstellung mehrfach ungesättigter Fettsäuren in Pflanzen
BR0317304A (pt) 2002-12-19 2005-11-08 Univ Bristol Processo para a produção de compostos, sequência de ácido nucleico isolada, sequência de aminoácidos, construção gênica, vetor, e, organismo
BRPI0407138A (pt) 2003-02-27 2006-01-10 Basf Plant Science Gmbh Sequência de ácido nucleico isolada, sequência de aminoácido, construção de gene, vetor, organismo transgênico não humano, processo para produzir ácidos graxos poliinsaturados, óleo, lipìdeo, ou um ácido graxo poliinsaturado ou uma fração dos mesmos, composições de óleo, de lipìdeos, ou de ácido graxo, e, uso do óleo, lipìdeos ou ácidos graxos ou de composições de óleo, de lipìdeos ou de ácido graxo
ES2421138T3 (es) 2003-03-31 2013-08-29 University Of Bristol Nuevas aciltransferasas vegetales específicas para ácidos grasos poliinsaturados de cadena larga
BRPI0409209A (pt) 2003-04-08 2006-03-28 Basf Plant Science Gmbh seqüência de ácido nucleico isolado, construto de gene, vetor, organismo não-humano transgênico, processo para produzir ácidos graxos poliinsaturados, óleo, lipìdeos ou ácidos graxos ou uma fração dos mesmos, composição de óleo, de lipìdeo ou de ácido graxo, e, uso de óleo, de lipìdeos ou de ácidos graxos ou de composição de óleo, de lipìdeo ou de ácido graxo
US11952581B2 (en) 2003-08-01 2024-04-09 Basf Plant Science Gmbh Process for the production of polyunsaturated fatty acids in transgenic organisms
EP2166069B2 (fr) 2003-08-01 2024-01-24 BASF Plant Science GmbH Procédé de production d'acides gras polyinsaturés chez des organismes transgéniques
JP4567047B2 (ja) 2004-02-27 2010-10-20 ビーエーエスエフ プラント サイエンス ゲーエムベーハー トランスジェニック植物における多価不飽和脂肪酸の製造方法
WO2005083053A2 (fr) 2004-02-27 2005-09-09 Basf Plant Science Gmbh Procede pour produire des acides gras $g(v)-3 insatures dans des organismes transgeniques
BR122019013214B1 (pt) 2004-04-22 2022-04-12 Commonwealth Scientific And Industrial Research Organisation Polinucleotídeo isolado, vetor, célula recombinante, método para produzir uma célula recombinante, método para produzir um ou mais ácido graxo(s) poliinsaturado de cadeia longa, método para produzir uma semente transgênica, método para produzir óleo, método para produzir uma semente oleaginosa, extrato da semente transgênica, composição compreendendo o referido extrato, ração e uso da referida célula recombinante ou extrato
US7807849B2 (en) 2004-04-22 2010-10-05 Commonwealth Scientific And Industrial Research Organisation Synthesis of long-chain polyunsaturated fatty acids by recombinant cells
DE102005013779A1 (de) 2005-03-22 2006-09-28 Basf Plant Science Gmbh Verfahren zur Herstellung von mehrfach ungesättigten C20- und C22-Fettsäuren mit mindestens vier Doppelbindungen in transgenen Pflanzen
DE102005038036A1 (de) 2005-08-09 2007-02-15 Basf Plant Science Gmbh Verfahren zur Herstellung von Arachidonsäure und/oder Eicosapentaensäure in transgenen Nutzpflanzen
GB2431158A (en) 2005-10-13 2007-04-18 Rothamsted Res Ltd Process for the production of arachidonic and/or eicosapentaenoic acid
DE102005052551A1 (de) 2005-11-02 2007-05-16 Rothamsted Res Harpenden Verfahren zur Herstellung von y-Linolensäure und/oder Stearidonsäure in transgenen Brassicaceae und Linaceae
GB0603160D0 (en) 2006-02-16 2006-03-29 Rothamsted Res Ltd Nucleic acid
AR059376A1 (es) 2006-02-21 2008-03-26 Basf Plant Science Gmbh Procedimiento para la produccion de acidos grasos poliinsaturados
US8629195B2 (en) 2006-04-08 2014-01-14 Bayer Materialscience Ag Production of polyurethane foams
WO2008022963A2 (fr) 2006-08-24 2008-02-28 Basf Plant Science Gmbh Isolation et caractérisation d'une nouvelle oméga-3 désaturase de pythium ayant une spécificité vis-à-vis de tous les acides gras oméga-6 ayant une chaîne plus longue que 18 atomes de carbone
WO2008025068A1 (fr) 2006-08-29 2008-03-06 Commonwealth Scientific And Industrial Research Organisation synthèse d'acides gras
ES2531391T3 (es) 2006-10-06 2015-03-13 Basf Plant Science Gmbh Delta-5 desaturasas y procedimiento para la preparación de ácidos grasos poliinsaturados en organismos transgénicos no humanos
CN101353661B (zh) * 2007-07-25 2012-05-09 中国科学院遗传与发育生物学研究所 具有△6脂肪酸脱氢酶功能的基因及其应用
CA2695112A1 (fr) 2007-07-31 2009-02-05 Basf Plant Science Gmbh Elongases et procedes de production d'acides gras polyinsatures dans des organismes transgeniques
EP2222856A2 (fr) 2007-12-14 2010-09-01 BASF Plant Science GmbH Promoteurs dérivés de brassica napus pour l'expression génétique spécifique de graines
WO2009133145A1 (fr) 2008-04-30 2009-11-05 Basf Plant Science Gmbh Désaturase et procédé pour la production d’acides gras polyinsaturés dans des organismes transgéniques
EP2318533A2 (fr) 2008-07-01 2011-05-11 BASF Plant Science GmbH Promoteurs de brassica napus pour l'expression de gènes spécifique de graines
WO2010023202A2 (fr) 2008-08-26 2010-03-04 Basf Plant Science Gmbh Acides nucléiques codant des désaturases et huile végétale modifiée
CA2743880C (fr) 2008-11-18 2020-08-18 James Robertson Petrie Cellules recombinantes possedant une activite elongase a5 exogene et methodes de production d'acide docosapentaenoique
AU2009326129B2 (en) 2008-12-12 2016-05-12 Basf Plant Science Gmbh Desaturases and process for the production of polyunsaturated fatty acids in transgenic organisms
AU2010247438B2 (en) 2009-05-13 2015-01-29 Basf Plant Science Company Gmbh Acyltransferases and uses thereof in fatty acid production
WO2011161093A1 (fr) 2010-06-25 2011-12-29 Basf Plant Science Company Gmbh Acyltransférases et leurs applications dans la production d'acides gras
WO2013113030A2 (fr) * 2012-01-26 2013-08-01 Cornell University Régulation des désaturases d'acides gras (fads)
CA2869738C (fr) 2012-04-12 2022-04-05 Rothamsted Research Ltd Production d'acides gras polyinsatures omega-3 a longue chaine
US9333202B2 (en) 2012-05-01 2016-05-10 The Trustees Of Columbia University In The City Of New York Non-retinoid antagonists for treatment of age-related macular degeneration and stargardt disease
MY187101A (en) 2012-06-15 2021-08-31 Commw Scient Ind Res Org Production of long chain polyunsaturated fatty acids in plant cells
WO2014151936A1 (fr) 2013-03-14 2014-09-25 The Trustees Of Columbia University In The City Of New York Octahydropyrrolopyrroles, leur préparation et leur utilisation
US9938291B2 (en) 2013-03-14 2018-04-10 The Trustess Of Columbia University In The City Of New York N-alkyl-2-phenoxyethanamines, their preparation and use
US9637450B2 (en) 2013-03-14 2017-05-02 The Trustees Of Columbia University In The City Of New York Octahydrocyclopentapyrroles, their preparation and use
EP3495357B1 (fr) 2013-03-14 2021-05-05 The Trustees of Columbia University in the City of New York 4-phénylpipéridines, leur préparation et leur utilisation
UA122768C2 (uk) 2013-12-18 2021-01-06 Коммонвелз Сайнтіфік Енд Індастріал Рисерч Организейшн Екстрагований рослинний ліпід, що містить довголанцюгові поліненасичені жирні кислоти
KR102429220B1 (ko) 2014-04-30 2022-08-04 더 트러스티이스 오브 콜롬비아 유니버시티 인 더 시티 오브 뉴욕 치환 4-페닐피페리딘, 그 제조 및 사용
AU2015281791A1 (en) 2014-06-27 2017-01-12 Commonwealth Scientific And Industrial Research Organisation Lipid comprising docosapentaenoic acid
CN107236679A (zh) * 2017-04-27 2017-10-10 广州弘宝元生物科技有限公司 一种高产不饱和脂肪酸重组工程菌株及其构建方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5614393A (en) * 1991-10-10 1997-03-25 Rhone-Poulenc Agrochimie Production of γ-linolenic acid by a Δ6-desaturase
EP0972029A1 (fr) * 1997-03-07 2000-01-19 Human Genome Sciences, Inc. Nouvelles proteines secretees

Also Published As

Publication number Publication date
EP1121150A1 (fr) 2001-08-08
WO2000021557A1 (fr) 2000-04-20
JP2002527051A (ja) 2002-08-27
EP1121150A4 (fr) 2003-06-04

Similar Documents

Publication Publication Date Title
CA2346006A1 (fr) Desaturase d'acide gras delta 6
Overby et al. Characterization of Flavin-containing monooxygenase-5 (FMO5) cloned from human and guinea-pig: Evidence that the unique catalytic properties of FMO5 are not confined to the rabbit ortholog
CA2343939A1 (fr) Genes et proteines predictifs et methodes therapeutiques destinees aux attaques, a l'hypertension, aux diabetes et a l'obesite
AU777187B2 (en) Novel mitogenic regulators
US5834293A (en) Cytochrome P450 arachidonic acid epoxygenase genetic mutation associated with hypertension
CA2379541A1 (fr) Polymorphismes dans les genes humains cyp3a4 et cyp3a7 et leurs applications en matiere de diagnostic et de therapie
US6280997B1 (en) Isolated nucleic acid molecule which codes for a 32 KDA protein having 11-CIS retinol dehydrogenase activity, and which associates with P63, a portion of a retinol binding protein receptor
US6159732A (en) Nucleic acid encoding mammalian Ubr1
US6399344B1 (en) Isolated proteins having retinol dehydrogenase activity, and which associate with retinol binding receptors
US5972646A (en) Isolated nucleic acid molecule which codes for a 32 kDa protein having 11-cis retinol dehydrogenase activity, and which associates with P63, a portion of a retinol binding protein receptor
Okamoto Molecular cloning of a novel variant of the rat soluble guanylate cyclase β2 subunit
CA2516777C (fr) Cyclo-oxygenase-3 humaine et ses utilisations
AU2006301579B2 (en) EGLN2 variants and use thereof in preventing or treating thromboembolic disorders and coronary heart diseases
AU748675B2 (en) Nucleic acid molecule encoding a 11-cis retinol dehydrogenase
JP2002519034A (ja) ヒト酸化還元酵素タンパク質
US20040126858A1 (en) Novel polypeptide-nadp dependent leukotriene b412-hydroxydehydrogenase-36 and the polynucleotide encoding said polypeptide
US20040096841A1 (en) Novel polypeptide-phosphatidic acid phsphatase 29.81 and the polynucleotide encoding said polypeptide
Overby et al. Are Not Confined to the Rabbit Ortholog
US20020165208A1 (en) Compositions and methods relating to hypertension
EP1396544A1 (fr) Acides nucléiques codant pour des déhydrogénases thyroidiennes humaines
CN1407098A (zh) 一种多肽——脂肪酶－9.57和编码这种多肽的多核苷酸
JP2003047479A (ja) ビタミンｄ３水酸化酵素
CA2368379A1 (fr) Polypeptides de proteine-kinase b.gamma. humaine et procede de dislocation de la proteine-kinase b.gamma. chez un sujet non humain
AU2005200019A1 (en) Novel mitogenic regulators
CN1407095A (zh) 一种多肽——果糖－1,6－二磷酸酶－16.61和编码这种多肽的多核苷酸

Legal Events

Date Code Title Description
FZDE Dead